InMed Pharmaceuticals (INM) Property, Plant & Equipment (Net) (2020 - 2026)
InMed Pharmaceuticals (INM) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 37.35 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 4.00 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 3.72 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 13.52 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 1.84 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 49,000.00 |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 2.53 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 90.90 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1.40 Bn |
| 10 | InMed Pharmaceuticals | 6.80 Mn | 1.56 Mn | - | 642,884.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 642,884.00 |
| Mar 31, 2026 | 642,884.00 |
| Dec 31, 2025 | 764,254.00 |
| Dec 31, 2025 | 764,254.00 |
| Sep 30, 2025 | 881,549.00 |
| Sep 30, 2025 | 881,549.00 |
| Jun 30, 2025 | 992,199.00 |
| Jun 30, 2025 | 992,199.00 |
| Mar 31, 2025 | 1.11 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 1.48 Mn |
| Dec 31, 2023 | 1.48 Mn |